May 3, 2024
As the Olympic torch heads toward Paris for the opening ceremony of the 2024 Olympics, another has left Paris en route to Milan, this one carried […]
May 3, 2024
Proton pump inhibitors (PPIs), which are used to control acid reflux, are associated with an increased risk for migraine and other severe headache types, new research […]
May 3, 2024
Listen Dr. Roach: Welcome to “Q&A with FDA,” where we aim to answer some of the most frequently asked questions that we’ve received from the public. […]
May 3, 2024
TOPLINE: Initiation of a high- vs low- baseline dose of an antipsychotic is tied to an elevated risk for psychosis conversion in high-risk patients, data from […]
May 3, 2024
Although artificial intelligence (AI) applications are increasingly prevalent in the healthcare sector each year, investment in digital health slowed down in Europe in 2023, according to […]
May 3, 2024
TOPLINE: Researchers have identified specific circulating microRNAs (miRNAs) in blood samples that can identify individuals at high risk of developing pancreatic cancer within 5 years, potentially […]
May 3, 2024
Expanding eligibility criteria is a strategy for improving the inclusion of traditionally underrepresented populations in clinical trials, according to a study. The results were published in […]
May 3, 2024
Diabetic neuropathy was the subject of a dedicated plenary session at the congress of the Francophone Diabetes Society. This already prevalent issue is becoming more prevalent […]
May 3, 2024
TOPLINE: iGlarLixi, a fixed-ratio combination of insulin glargine and the glucagon-like peptide-1 receptor agonist (GLP-1 RA) lixisenatide, improves glycemic control, with a low rate of hypoglycemia, […]